Precision medicine using whole genome sequencing identifies a novel dystrophin (DMD) variant for X‐linked muscular dystrophy in a cat

Abstract Background Muscular dystrophies (MDs) are a large, heterogeneous group of degenerative muscle diseases. X‐linked dystrophin‐deficient MD in cats is the first genetically characterized cat model for a human disease and a few novel forms have been identified. Hypothesis/Objectives Muscular dy...

Full description

Bibliographic Details
Main Authors: G. Diane Shelton, Fabrizio Tucciarone, Ling T. Guo, Lyndon M. Coghill, Leslie A. Lyons
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Journal of Veterinary Internal Medicine
Subjects:
Online Access:https://doi.org/10.1111/jvim.16971
_version_ 1797349551795863552
author G. Diane Shelton
Fabrizio Tucciarone
Ling T. Guo
Lyndon M. Coghill
Leslie A. Lyons
author_facet G. Diane Shelton
Fabrizio Tucciarone
Ling T. Guo
Lyndon M. Coghill
Leslie A. Lyons
author_sort G. Diane Shelton
collection DOAJ
description Abstract Background Muscular dystrophies (MDs) are a large, heterogeneous group of degenerative muscle diseases. X‐linked dystrophin‐deficient MD in cats is the first genetically characterized cat model for a human disease and a few novel forms have been identified. Hypothesis/Objectives Muscular dystrophy was suspected in a young male domestic shorthair cat. Clinical, molecular, and genetic techniques could provide a definitive diagnosis. Animals A 1‐year‐old male domestic shorthair cat presented for progressive difficulty walking, macroglossia and dysphagia beginning at 6 months of age. The tongue was thickened, protruded with constant ptyalism, and thickening and rigidity of the neck and shoulders were observed. Methods A complete neurological examination, baseline laboratory evaluation and biopsies of the trapezius muscle were performed with owner consent. Indirect immunofluorescence staining of muscle cryosections was performed using several monoclonal and polyclonal antibodies against dystrophy‐associated proteins. DNA was isolated for genomic analyses by whole genome sequencing and comparison to DNA variants in the 99 Lives Cat Genome Sequencing dataset. Results and Clinical Importance Aspartate aminotransferase (687 IU/L) and creatine kinase (24 830 IU/L) activities were increased and mild hypokalemia (3.7 mmol/L) was present. Biopsy samples from the trapezius muscle confirmed a degenerative and regenerative myopathy and protein alterations identified by immunohistochemistry resulted in a diagnosis of a in dystrophin‐deficient form of X‐linked MD. A stop gain variant (c.4849C>T; p.Gln1617Ter) dystrophin was identified by genome sequencing. Precision/genomic medicine efforts for the domestic cat and in veterinary medicine support disease variant and animal model discovery and provide opportunities for targeted treatments for companion animals.
first_indexed 2024-03-08T12:31:57Z
format Article
id doaj.art-09b39a86188e450caec7328ebde389b7
institution Directory Open Access Journal
issn 0891-6640
1939-1676
language English
last_indexed 2024-03-08T12:31:57Z
publishDate 2024-01-01
publisher Wiley
record_format Article
series Journal of Veterinary Internal Medicine
spelling doaj.art-09b39a86188e450caec7328ebde389b72024-01-22T02:05:50ZengWileyJournal of Veterinary Internal Medicine0891-66401939-16762024-01-0138113514410.1111/jvim.16971Precision medicine using whole genome sequencing identifies a novel dystrophin (DMD) variant for X‐linked muscular dystrophy in a catG. Diane Shelton0Fabrizio Tucciarone1Ling T. Guo2Lyndon M. Coghill3Leslie A. Lyons4Department of Pathology, School of Medicine University of California San Diego La Jolla California USAAbington Park Vets Referrals Northampton United KingdomDepartment of Pathology, School of Medicine University of California San Diego La Jolla California USADepartment of Veterinary Pathobiology, College of Veterinary Medicine University of Missouri Columbia Missouri USADepartment of Veterinary Pathobiology, College of Veterinary Medicine University of Missouri Columbia Missouri USAAbstract Background Muscular dystrophies (MDs) are a large, heterogeneous group of degenerative muscle diseases. X‐linked dystrophin‐deficient MD in cats is the first genetically characterized cat model for a human disease and a few novel forms have been identified. Hypothesis/Objectives Muscular dystrophy was suspected in a young male domestic shorthair cat. Clinical, molecular, and genetic techniques could provide a definitive diagnosis. Animals A 1‐year‐old male domestic shorthair cat presented for progressive difficulty walking, macroglossia and dysphagia beginning at 6 months of age. The tongue was thickened, protruded with constant ptyalism, and thickening and rigidity of the neck and shoulders were observed. Methods A complete neurological examination, baseline laboratory evaluation and biopsies of the trapezius muscle were performed with owner consent. Indirect immunofluorescence staining of muscle cryosections was performed using several monoclonal and polyclonal antibodies against dystrophy‐associated proteins. DNA was isolated for genomic analyses by whole genome sequencing and comparison to DNA variants in the 99 Lives Cat Genome Sequencing dataset. Results and Clinical Importance Aspartate aminotransferase (687 IU/L) and creatine kinase (24 830 IU/L) activities were increased and mild hypokalemia (3.7 mmol/L) was present. Biopsy samples from the trapezius muscle confirmed a degenerative and regenerative myopathy and protein alterations identified by immunohistochemistry resulted in a diagnosis of a in dystrophin‐deficient form of X‐linked MD. A stop gain variant (c.4849C>T; p.Gln1617Ter) dystrophin was identified by genome sequencing. Precision/genomic medicine efforts for the domestic cat and in veterinary medicine support disease variant and animal model discovery and provide opportunities for targeted treatments for companion animals.https://doi.org/10.1111/jvim.16971animal modelsFelis catusprecision medicinewhole genome sequencing
spellingShingle G. Diane Shelton
Fabrizio Tucciarone
Ling T. Guo
Lyndon M. Coghill
Leslie A. Lyons
Precision medicine using whole genome sequencing identifies a novel dystrophin (DMD) variant for X‐linked muscular dystrophy in a cat
Journal of Veterinary Internal Medicine
animal models
Felis catus
precision medicine
whole genome sequencing
title Precision medicine using whole genome sequencing identifies a novel dystrophin (DMD) variant for X‐linked muscular dystrophy in a cat
title_full Precision medicine using whole genome sequencing identifies a novel dystrophin (DMD) variant for X‐linked muscular dystrophy in a cat
title_fullStr Precision medicine using whole genome sequencing identifies a novel dystrophin (DMD) variant for X‐linked muscular dystrophy in a cat
title_full_unstemmed Precision medicine using whole genome sequencing identifies a novel dystrophin (DMD) variant for X‐linked muscular dystrophy in a cat
title_short Precision medicine using whole genome sequencing identifies a novel dystrophin (DMD) variant for X‐linked muscular dystrophy in a cat
title_sort precision medicine using whole genome sequencing identifies a novel dystrophin dmd variant for x linked muscular dystrophy in a cat
topic animal models
Felis catus
precision medicine
whole genome sequencing
url https://doi.org/10.1111/jvim.16971
work_keys_str_mv AT gdianeshelton precisionmedicineusingwholegenomesequencingidentifiesanoveldystrophindmdvariantforxlinkedmusculardystrophyinacat
AT fabriziotucciarone precisionmedicineusingwholegenomesequencingidentifiesanoveldystrophindmdvariantforxlinkedmusculardystrophyinacat
AT lingtguo precisionmedicineusingwholegenomesequencingidentifiesanoveldystrophindmdvariantforxlinkedmusculardystrophyinacat
AT lyndonmcoghill precisionmedicineusingwholegenomesequencingidentifiesanoveldystrophindmdvariantforxlinkedmusculardystrophyinacat
AT lesliealyons precisionmedicineusingwholegenomesequencingidentifiesanoveldystrophindmdvariantforxlinkedmusculardystrophyinacat